International models of investigator-initiated trials: implications for Japan.

ABSTRACT:

Background

Academic/institutional investigator-initiated clinical trials benefit individuals and society by supplementing gaps in industry-sponsored clinical trials.

Materials

In May 2010, experts from Japan, the Republic of Korea, the UK, and the United States, met at a symposium in Tokyo, Japan, to discuss how policies related to the conduct of clinical trials, which have been shown to be effective, may be applied to other regions of the world.

Results

In order to increase the availability of anticancer drugs world-wide, nations including Japan should examine the benefits of increasing the number of investigator-initiated clinical trials. These trials represent one of the most effective ways to translate basic scientific knowledge into clinical practice. These trial

SUBMITTER: Trimble EL 

PROVIDER: S-EPMC3501232 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature